Gemtuzumab and diarrhoea Patient Reports February 13, 2012



Gemtuzumab Side Effects Report #4907159-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from TURKEY on Jan 23, 2006. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: budd-chiari syndrome, diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, respiratory tract infection fungal. Gemtuzumab dosage: 10 MG 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, LEVOTHYROXINE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4869294-2
Gemtuzumab side effect was reported by a Health Professional from AUSTRALIA on Aug 22, 2002. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bundle branch block, cardiac failure congestive, chest pain What is  chest pain, diarrhoea, febrile neutropenia, fluid retention, gingivitis, pancytopenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, PARACETAMOL, PROMETHAZINE HYDROCHLORIDE, ALLOPURINOL, FUROSEMIDE, HYDROCORTISONE, ESTRADIOL. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5028048-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 29, 2005. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood disorder, diarrhoea, haemoglobin decreased, lethargy, loss of consciousness, lower respiratory tract infection, neutrophil count decreased. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4911211-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from AUSTRALIA on Jan 15, 2002. Male patient, 41 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, blood urea increased, diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, hepatic cyst, laboratory test abnormal, melaena. Gemtuzumab dosage: 9 MG/M^2 1X PER DOS, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died.


Gemtuzumab Side Effects Report #4867739-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Male patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial flutter, chills, coagulopathy, diarrhoea, haemodynamic instability, herpes simplex What is  herpes simplex, hypokalaemia, hypomagnesaemia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 07/11/1998.

Gemtuzumab Side Effects Report #5246876-X
Gemtuzumab side effect was reported by a Physician from NETHERLANDS on Feb 14, 2007. Female patient was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchitis What is  bronchitis, diarrhoea, fatigue, febrile neutropenia, nausea What is  nausea. Gemtuzumab dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, MAALOX FAST BLOCKER. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6133987-X
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Mar 25, 2009. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, antiemetic supportive care, antifungal prophylaxis and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: central line infection, clostridial infection, diarrhoea, liver function test abnormal, neutropenic sepsis, septic embolus. Gemtuzumab dosage: 4.7 MG EVERY 1 TOT. During the same period patient was treated with ALLOPURINOL, PARACETAMOL, DAUNORUBICIN, ONDANSETRON, ITRACONAZOLE. Patient recovered.

Gemtuzumab Side Effects Report #4617014-9
Gemtuzumab side effect was reported by a Physician from on Mar 07, 2005. Female patient, 63 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: arrhythmia What is  arrhythmia, cardiac arrest What is  cardiac arrest, diarrhoea, hypokalaemia. Gemtuzumab dosage: 10 MG 1 X PER 1 DAY. During the same period patient was treated with ACYCLOVIR, CYTARABINE, IDARUBICIN, VANCOMYCIN, CEFTAZIDIME. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4694603-7
Gemtuzumab side effect was reported by a Health Professional from on June 14, 2005. Female patient, 63 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: arrhythmia What is  arrhythmia, cardiac arrest What is  cardiac arrest, diarrhoea, hypokalaemia. Gemtuzumab dosage: 10 MG 1X PER 1 DAY,. During the same period patient was treated with ACYCLOVIR, CYTARABINE, IDARUBICIN, VANCOMYCIN, CEFTAZIDIME. Patient was hospitalized. Patient died.


Gemtuzumab Side Effects Report #4846935-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on Nov 28, 2005. Female patient, 63 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cardiac arrest What is  cardiac arrest, diarrhoea, hypokalaemia, ventricular fibrillation. Gemtuzumab dosage: 10 MG 1X PER 1 DAY. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME, ACYCLOVIR, CYTARABINE, IDARUBICIN. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5298828-1
Gemtuzumab side effect was reported by a Physician from ITALY on Apr 05, 2007. Female patient, weighting 202.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, circulatory collapse, diarrhoea, pyrexia, shock, vomiting. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ONDANSETRON, ACYCLOVIR, SERTRALINE, IDARUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/29/2007.

Gemtuzumab Side Effects Report #5354356-6
Gemtuzumab side effect was reported by a Physician from ITALY on June 01, 2007. Female patient, weighting 202.8 lb, was diagnosed with acute myeloid leukaemia, vomiting and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, circulatory collapse, diarrhoea, pyrexia, septic shock, vomiting. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ONDANSETRON, ACYCLOVIR, SERTRALINE, IDARUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/29/2007.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Gemtuzumab